Using a non-human primate model of the autoimmune neuroinflammatory disease multiple sclerosis (MS), we have unraveled the role of B cells in the making and breaking of immune tolerance against central nervous system myelin. It is discussed here that B cells prevent the activation of strongly pathogenic T cells present in the naïve repertoire, which are directed against the immunodominant myelin antigen MOG (myelin oligodendrocyte glycoprotein). Prevention occurs via destructive processing of a critical epitope (MOG34-56) through the lysosomal serine protease cathepsin G. This effective tolerance mechanism is abrogated when the B cells are infected with Epstein–Barr virus, a ubiquitous γ1-herpesvirus that entails the strongest non-genetic r...
CD20-positive B-cell depletion is a highly promising treatment for multiple sclerosis (MS), but the ...
The absence of pathological hallmarks of progressive multiple sclerosis (MS) in commonly used rodent...
The serine protease cathepsin (Cat) G dominates the proteolytic processing of the multiple sclerosis...
The efficacy of B cell depletion therapy in multiple sclerosis indicates their central pathogenic ro...
EBV is the major infectious environmental risk factor for multiple sclerosis (MS), but the underlyin...
<div><p>The cysteine cathepsins B, S, and L are functionally linked to antigen processing, and hence...
Epstein Barr Virus (EBV) is a major risk factor in Multiple Sclerosis (MS), via as yet unclear mecha...
Multiple sclerosis (MS) is an inflammatory, demyelinating, central nervous system disease mediated b...
Experimental autoimmune encephalomyelitis (EAE) is an animal model of the human autoimmune disease, ...
The neuroinflammatory disease multiple sclerosis is driven by autoimmune pathology in the central ne...
Multiple sclerosis (MS) is an inflammatory, demyelinating, central nervous system disease mediated b...
International audienceMultiple sclerosis (MS) is a chronic inflammatory disease resulting in demyeli...
Background Myelin oligodendrocyte glycoprotein (MOG) is a candidate primary target of the autoimmune...
The efficacy of B cell depletion therapy in multiple sclerosis indicates their central pathogenic ro...
Multiple sclerosis (MS) is thought to be initiated by the interaction of genetic and environmental f...
CD20-positive B-cell depletion is a highly promising treatment for multiple sclerosis (MS), but the ...
The absence of pathological hallmarks of progressive multiple sclerosis (MS) in commonly used rodent...
The serine protease cathepsin (Cat) G dominates the proteolytic processing of the multiple sclerosis...
The efficacy of B cell depletion therapy in multiple sclerosis indicates their central pathogenic ro...
EBV is the major infectious environmental risk factor for multiple sclerosis (MS), but the underlyin...
<div><p>The cysteine cathepsins B, S, and L are functionally linked to antigen processing, and hence...
Epstein Barr Virus (EBV) is a major risk factor in Multiple Sclerosis (MS), via as yet unclear mecha...
Multiple sclerosis (MS) is an inflammatory, demyelinating, central nervous system disease mediated b...
Experimental autoimmune encephalomyelitis (EAE) is an animal model of the human autoimmune disease, ...
The neuroinflammatory disease multiple sclerosis is driven by autoimmune pathology in the central ne...
Multiple sclerosis (MS) is an inflammatory, demyelinating, central nervous system disease mediated b...
International audienceMultiple sclerosis (MS) is a chronic inflammatory disease resulting in demyeli...
Background Myelin oligodendrocyte glycoprotein (MOG) is a candidate primary target of the autoimmune...
The efficacy of B cell depletion therapy in multiple sclerosis indicates their central pathogenic ro...
Multiple sclerosis (MS) is thought to be initiated by the interaction of genetic and environmental f...
CD20-positive B-cell depletion is a highly promising treatment for multiple sclerosis (MS), but the ...
The absence of pathological hallmarks of progressive multiple sclerosis (MS) in commonly used rodent...
The serine protease cathepsin (Cat) G dominates the proteolytic processing of the multiple sclerosis...